Mission of NanoGroup is to build a cluster of medical and biotechnological companies active in the field of diagnostics, therapy and rehabilitation of oncological patients.
Currently, the group is managing five technologically advanced nanoengineering projects organized under three specialized startups.
NanoGroup plans to sell licenses to its early-stage solutions (pre-clinical and clinical phase 1st) to international biotech companies and pharmaceutical companies.
2013
Served areaWorldwide
HeadquartersRakowiecka 36, 02-532 Warszawa – Poland
20,097,459
IPODec. 1, 2017
Stock exchange(s)Warsaw Stock Exchange
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.